Table 4 Comparison of PARP1 selective inhibitors and selected first-generation PARP inhibitors

From: A new wave of innovations within the DNA damage response

Drugs

Olaparib

Talazoparib

NMS03305293

AZD5305

AZD9547

PARP1 IC50 (μM)a

0.007

0.009

<0.01

0.003

<0.005

PARP2 IC50 (μM)a

0.006

0.030

0.691

>1.4

>93

PARP1/2 selectivity fold

1

3

>200

>460

19107

PARP3/5a/6 IC50 (μM)a

0.2/70/1.8

0.2/1.9.1.1

0.5/>10/not reported

3.4/ > 89/26

All > 100

PARP1 trappingb

+

++

-

++

Yes

PARP2 trappingb

+

++

-

-

-

DLD1 BRCA2−/− cell line antiprolifertive GI50 (nM)

11

0.5

Not reported

0.4

1.4

Pgp substrate

Yes

Yes

No

Yes

No

CNS penetration

Limited, Rat/Monkey Kpuu: <0.03/<0.1

Limited, Rat Kpuu: <0.03

Yes, with a brain/plasma ratio of 4-10 in rats and mouse

Limited, Rat/Monkey Kpuu: <0.05/<0.01

Yes, with Rat Kpuu 0.31

  1. aDetermined by a fluorescence polarization assay
  2. bDetermined by an immunofluorescence–based assay